Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine

Cancer Treat Rep. 1978 Apr;62(4):567-9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Altretamine / therapeutic use*
  • Bleomycin / therapeutic use*
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Squamous Cell / drug therapy*
  • Clinical Trials as Topic
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Drug Resistance
  • Female
  • Humans
  • Lomustine / therapeutic use*
  • Lung Neoplasms / drug therapy*
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Nitrosourea Compounds / therapeutic use*
  • Procarbazine / therapeutic use
  • Triazines / therapeutic use*

Substances

  • Nitrosourea Compounds
  • Triazines
  • Bleomycin
  • Procarbazine
  • Lomustine
  • Doxorubicin
  • Cyclophosphamide
  • Altretamine
  • Methotrexate